Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 1/2 3Phase NA 2Phase 1 2Phase 2 1

Status

Completed 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 146Leukemia 49Precursor Cell Lymphoblastic Leukemia-Lymphoma 46Congenital Abnormalities 30Myelodysplastic Syndromes 25Leukemia, Monocytic, Acute 23Recurrence 22Leukemia, Myelomonocytic, Acute 22Leukemia, Erythroblastic, Acute 20Leukemia, Megakaryoblastic, Acute 19Lymphoma 17Leukemia, Biphenotypic, Acute 13Lymphoma, Non-Hodgkin 12Burkitt Lymphoma 12Lymphoma, Large B-Cell, Diffuse 11Leukemia, Myelomonocytic, Chronic 11Blast Crisis 11Lymphoma, Mantle-Cell 9Leukemia, Lymphocytic, Chronic, B-Cell 9Lymphoma, Follicular 8Lymphoma, Large-Cell, Immunoblastic 7Leukemia, Eosinophilic, Acute 7Leukemia, Basophilic, Acute 7Myeloproliferative Disorders 6Lymphoma, B-Cell, Marginal Zone 6Hodgkin Disease 6Hematologic Neoplasms 6Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Promyelocytic, Acute 5Leukemia, Myeloid, Accelerated Phase 5

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Cytarabine × Clear all
NCT02834390 2025-03-05

Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)

Daiichi Sankyo

Phase 1 Completed
7 enrolled 16 charts
Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute

NCT00470197 2013-09-30

Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
35 enrolled
LymphoidOther hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neoplasms, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡